Alex C Liber1,2, Jeffrey M Drope1, Michal Stoklosa1. 1. Economic and Health Policy Research, Intramural Research Department, American Cancer Society, Atlanta, Georgia, USA. 2. Health Management and Policy Department, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Abstract
BACKGROUND: Some scholars suggest that price differences between combustible cigarettes and e-cigarettes could be effective in moving current combustible smokers to e-cigarettes, which could reduce tobacco-related death and disease. Currently, in most jurisdictions, e-cigarettes are not subject to the same excise taxes as combustible cigarettes, potentially providing the category with a price advantage over combustible cigarettes. This paper tests whether e-cigarettes tax advantage has translated into a price advantage. METHODS: In a sample of 45 countries, the price of combustible cigarettes, disposable e-cigarettes and rechargeable cigarettes were compared. RESULTS: Comparable units of combustible cigarettes cost less than disposable e-cigarettes in almost every country in the sample. While the e-liquids consumed in rechargeable e-cigarettes might cost less per comparable unit than combustible cigarettes, the initial cost to purchase a rechargeable e-cigarette presents a significant cost barrier to switching from smoking to vaping. DISCUSSION: Existing prices of e-cigarettes are generally much higher than of combustible cigarettes. If policymakers wish to tax e-cigarettes less than combustibles, forceful policy action-almost certainly through excise taxation-must raise the price of combustible cigarettes beyond the price of using e-cigarettes. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: Some scholars suggest that price differences between combustible cigarettes and e-cigarettes could be effective in moving current combustible smokers to e-cigarettes, which could reduce tobacco-related death and disease. Currently, in most jurisdictions, e-cigarettes are not subject to the same excise taxes as combustible cigarettes, potentially providing the category with a price advantage over combustible cigarettes. This paper tests whether e-cigarettes tax advantage has translated into a price advantage. METHODS: In a sample of 45 countries, the price of combustible cigarettes, disposable e-cigarettes and rechargeable cigarettes were compared. RESULTS: Comparable units of combustible cigarettes cost less than disposable e-cigarettes in almost every country in the sample. While the e-liquids consumed in rechargeable e-cigarettes might cost less per comparable unit than combustible cigarettes, the initial cost to purchase a rechargeable e-cigarette presents a significant cost barrier to switching from smoking to vaping. DISCUSSION: Existing prices of e-cigarettes are generally much higher than of combustible cigarettes. If policymakers wish to tax e-cigarettes less than combustibles, forceful policy action-almost certainly through excise taxation-must raise the price of combustible cigarettes beyond the price of using e-cigarettes. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Entities:
Keywords:
Economics; Electronic nicotine delivery devices; Public policy; Taxation
Authors: Jennifer L Pearson; Sara C Hitchman; Leonie S Brose; Linda Bauld; Allison M Glasser; Andrea C Villanti; Ann McNeill; David B Abrams; Joanna E Cohen Journal: Tob Control Date: 2017-06-17 Impact factor: 7.552
Authors: Scott R Weaver; J Wesley Heath; David L Ashley; Jidong Huang; Terry F Pechacek; Michael P Eriksen Journal: Drug Alcohol Depend Date: 2020-02-11 Impact factor: 4.492
Authors: Patricia Simon; Deepa R Camenga; Meghan E Morean; Grace Kong; Krysten W Bold; Dana A Cavallo; Suchitra Krishnan-Sarin Journal: Prev Med Date: 2018-04-17 Impact factor: 4.018
Authors: Allison M Glasser; Lauren Collins; Jennifer L Pearson; Haneen Abudayyeh; Raymond S Niaura; David B Abrams; Andrea C Villanti Journal: Am J Prev Med Date: 2016-11-30 Impact factor: 5.043